These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Synthesis and biological investigation of novel tricyclic benzodiazepinedione-based RGD analogues. Addicks E; Mazitschek R; Giannis A Chembiochem; 2002 Nov; 3(11):1078-88. PubMed ID: 12404633 [TBL] [Abstract][Full Text] [Related]
9. Incorporation of thioether building blocks into an alphavbeta3-specific RGD peptide: synthesis and biological activity. Kelleman A; Mattern RH; Pierschbacher MD; Goodman M Biopolymers; 2003; 71(6):686-95. PubMed ID: 14991678 [TBL] [Abstract][Full Text] [Related]
10. Probing for integrin alpha v beta3 binding of RGD peptides using fluorescence polarization. Wang W; Wu Q; Pasuelo M; McMurray JS; Li C Bioconjug Chem; 2005; 16(3):729-34. PubMed ID: 15898744 [TBL] [Abstract][Full Text] [Related]
11. Combinatorial chemistry reveals a new motif that binds the platelet fibrinogen receptor, gpIIbIIIa. Thorpe DS; Yeoman H; Chan AW; Krchnak V; Lebl M; Felder S Biochem Biophys Res Commun; 1999 Mar; 256(3):537-41. PubMed ID: 10080933 [TBL] [Abstract][Full Text] [Related]
12. [Development of Novel Functional Molecules Based on the Molecular Structure Characteristics of Diketopiperazines]. Nakao M Yakugaku Zasshi; 2017; 137(12):1505-1516. PubMed ID: 29199259 [TBL] [Abstract][Full Text] [Related]
14. Preparation and evaluation of glycosylated arginine-glycine-aspartate (RGD) derivatives for integrin targeting. Kuijpers BH; Groothuys S; Soede AC; Laverman P; Boerman OC; van Delft FL; Rutjes FP Bioconjug Chem; 2007; 18(6):1847-54. PubMed ID: 17922547 [TBL] [Abstract][Full Text] [Related]
15. Microwave-assisted solid-phase synthesis of 2,5-diketopiperazines: solvent and resin dependence. Tullberg M; Luthman K; Grøtli M J Comb Chem; 2006; 8(6):915-22. PubMed ID: 17096581 [TBL] [Abstract][Full Text] [Related]
16. Non-peptide RGD surrogates which mimic a Gly-Asp beta-turn: potent antagonists of platelet glycoprotein IIb-IIIa. Fisher MJ; Gunn B; Harms CS; Kline AD; Mullaney JT; Nunes A; Scarborough RM; Arfsten AE; Skelton MA; Um SL; Utterback BG; Jakubowski JA J Med Chem; 1997 Jun; 40(13):2085-101. PubMed ID: 9207949 [TBL] [Abstract][Full Text] [Related]
17. Targeting integrins: insights into structure and activity of cyclic RGD pentapeptide mimics containing azabicycloalkane amino acids. Belvisi L; Bernardi A; Colombo M; Manzoni L; Potenza D; Scolastico C; Giannini G; Marcellini M; Riccioni T; Castorina M; LoGiudice P; Pisano C Bioorg Med Chem; 2006 Jan; 14(1):169-80. PubMed ID: 16214345 [TBL] [Abstract][Full Text] [Related]
18. The relative orientation of the Arg and Asp side chains defined by a pseudodihedral angle as a key criterion for evaluating the structure-activity relationship of RGD peptides. Kostidis S; Stavrakoudis A; Biris N; Tsoukatos D; Sakarellos C; Tsikaris V J Pept Sci; 2004 Aug; 10(8):494-509. PubMed ID: 15347137 [TBL] [Abstract][Full Text] [Related]
19. Immunosuppressory activity of the cyclodimeric peptide with RGD-sequences. Szewczuk Z; Buczek P; Stefanowicz P; Krajewski K; Wieczorek Z; Siemion IZ Acta Biochim Pol; 2001; 48(1):121-30. PubMed ID: 11440161 [TBL] [Abstract][Full Text] [Related]
20. Structure-based understanding of ligand affinity using human thrombin as a model system. Nienaber VL; Mersinger LJ; Kettner CA Biochemistry; 1996 Jul; 35(30):9690-9. PubMed ID: 8703940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]